| Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography–staged treatment-naive patients with Hodgkin lymphoma TC El-Galaly, F d'Amore, KJ Mylam, P de Nully Brown, M Bøgsted, A Bukh, ... Journal of clinical oncology 30 (36), 4508-4514, 2012 | 336 | 2012 |
| Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis K Dybkær, M Bøgsted, S Falgreen, JS Bødker, MK Kjeldsen, A Schmitz, ... Journal of Clinical Oncology 33 (12), 1379, 2015 | 122 | 2015 |
| Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG JL Brady, MS Binkley, C Hajj, M Chelius, K Chau, A Balogh, M Levis, ... Blood, The Journal of the American Society of Hematology 133 (3), 237-245, 2019 | 121 | 2019 |
| Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma TC El-Galaly, CY Cheah, MD Bendtsen, GS Nowakowski, R Kansara, ... European Journal of Cancer 93, 57-68, 2018 | 120 | 2018 |
| Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies G Thanarajasingam, LM Minasian, F Baron, F Cavalli, RA De Claro, ... The Lancet Haematology 5 (11), e563-e598, 2018 | 116 | 2018 |
| FDG‐PET/CT in the management of lymphomas: current status and future directions TC El‐Galaly, D Villa, LC Gormsen, J Baech, A Lo, CY Cheah Journal of internal medicine 284 (4), 358-376, 2018 | 112 | 2018 |
| Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs TC El-Galaly, KJ Mylam, P Brown, L Specht, I Christiansen, L Munksgaard, ... Haematologica 97 (6), 931, 2012 | 99* | 2012 |
| Routine imaging for diffuse large B-cell lymphoma in first complete remission does not improve post-treatment survival: a Danish-Swedish population-based study TC El-Galaly, LH Jakobsen, M Hutchings, P de Nully Brown, ... J Clin Oncol 33 (34), 3993-3998, 2015 | 96 | 2015 |
| The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: an international multicenter … TC El-Galaly, D Villa, TY Michaelsen, M Hutchings, NG Mikhaeel, ... European journal of cancer 75, 195-203, 2017 | 92 | 2017 |
| Minimal loss of lifetime for patients with diffuse large B-cell lymphoma in remission and event free 24 months after treatment: a Danish population-based study LH Jakobsen, M Bøgsted, PN Brown, B Arboe, J Jørgensen, TS Larsen, ... Journal of Clinical Oncology 35 (7), 778-784, 2017 | 91 | 2017 |
| Outcome prediction by extranodal involvement, IPI, R‐IPI, and NCCN‐IPI in the PET/CT and rituximab era: AD anish–C anadian study of 443 patients with diffuse‐large B‐cell lymphoma TC El‐Galaly, D Villa, M Alzahrani, JW Hansen, LH Sehn, D Wilson, ... American Journal of Hematology 90 (11), 1041-1046, 2015 | 86 | 2015 |
| miR‐155 as a biomarker in B‐cell malignancies H Due, P Svendsen, JS Bødker, A Schmitz, M Bøgsted, HE Johnsen, ... BioMed research international 2016 (1), 9513037, 2016 | 83 | 2016 |
| The Danish national lymphoma registry: coverage and data quality B Arboe, TC El-Galaly, MR Clausen, PS Munksgaard, D Stoltenberg, ... PLoS One 11 (6), e0157999, 2016 | 79 | 2016 |
| PET/CT for staging; past, present, and future TC El-Galaly, LC Gormsen, M Hutchings Seminars in nuclear medicine 48 (1), 4-16, 2018 | 76 | 2018 |
| Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: a Danish population-based cohort study MB Juul, PH Jensen, H Engberg, S Wehberg, A Dessau-Arp, D Haziri, ... European Journal of Cancer 99, 86-96, 2018 | 74 | 2018 |
| The myeloma stem cell concept, revisited: from phenomenology to operational terms HE Johnsen, M Bøgsted, A Schmitz, JS Bødker, TC El-Galaly, P Johansen, ... Haematologica 101 (12), 1451, 2016 | 68 | 2016 |
| Role of routine imaging in detecting recurrent lymphoma: a review of 258 patients with relapsed aggressive non‐Hodgkin and Hodgkin lymphoma TC El‐Galaly, KJ Mylam, M Bøgsted, P Brown, M Rossing, AO Gang, ... American journal of hematology 89 (6), 575-580, 2014 | 64 | 2014 |
| Burkitt lymphoma international prognostic index AJ Olszewski, LH Jakobsen, GP Collins, K Cwynarski, V Bachanova, ... Journal of clinical oncology 39 (10), 1129-1138, 2021 | 63 | 2021 |
| The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study M Alzahrani, TC El-Galaly, M Hutchings, JW Hansen, A Loft, HE Johnsen, ... Annals of Oncology 27 (6), 1095-1099, 2016 | 61 | 2016 |
| Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients MR Wilson, TA Eyre, AA Kirkwood, N Wong Doo, C Soussain, S Choquet, ... Blood, The Journal of the American Society of Hematology 139 (16), 2499-2511, 2022 | 60 | 2022 |
